Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

13.3K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
13.3K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

2.1K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
2.1K
Drug-Receptor Bonds01:25

Drug-Receptor Bonds

3.3K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
3.3K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
Principles of Drug Action01:24

Principles of Drug Action

6.6K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
6.6K
Protein-Drug Binding: Mechanism and Kinetics01:16

Protein-Drug Binding: Mechanism and Kinetics

954
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
954

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition.

Journal of the American Chemical Society·2026
Same author

Ratiometric transcriptional activation by protein degradation.

bioRxiv : the preprint server for biology·2026
Same author

Activating p53<sup>Y220C</sup> with a mutant-specific small molecule.

Nature communications·2026
Same author

Charged molecular glue discovery enabled by targeted degron display.

Nature chemical biology·2026
Same author

A druggable redox switch on SHP1 controls macrophage inflammation.

Nature chemical biology·2026
Same author

Degraders of the dengue virus capsid protein exhibit differentiated pharmacology relative to capsid inhibitors.

Nature communications·2026

Related Experiment Video

Updated: Sep 14, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K

Generating Surprisingly Powerful Pharmacology from Chemically Induced Protein Interactions.

Stephen M Hinshaw1, Steven M Banik2, Nathanael S Gray1

  • 1Department of Chemical and Systems Biology, ChEM-H, and Stanford Cancer Institute, Stanford School of Medicine, Stanford University, Stanford, California 94305, United States.

Accounts of Chemical Research
|July 24, 2025
PubMed
Summary

Small molecules that induce protein proximity are revolutionizing cellular research and medicine. New therapeutic strategies are emerging, with targeted protein degradation being a key example of this exciting field.

More Related Videos

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.9K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

Related Experiment Videos

Last Updated: Sep 14, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.1K
Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
10:17

Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library

Published on: January 14, 2020

7.9K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

Area of Science:

  • Biochemistry
  • Chemical Biology
  • Molecular Pharmacology

Background:

  • Small molecules inducing protein proximity are powerful tools for studying cellular processes.
  • Proximity-inducing agents, including biologics, are increasingly used clinically for diverse targets and diseases.
  • Targeted protein degradation is a major therapeutic approach driven by proximity-dependent mechanisms.

Purpose of the Study:

  • To explore the principles of proximity pharmacology.
  • To identify novel therapeutic mechanisms actionable through chemically induced protein interactions.
  • To highlight promising areas for future innovation in proximity-based drug discovery.

Main Methods:

  • Review of general principles in proximity pharmacology.
  • Analysis of current applications and emerging design strategies for proximity-inducing molecules.
  • Identification of underexplored biochemical mechanisms for targeted protein interactions.

Main Results:

  • Small molecules and biologics that induce protein proximity have significant applications in research and therapy.
  • Targeted protein degradation exemplifies a successful proximity-dependent therapeutic strategy.
  • Numerous unexplored pharmacological mechanisms exist for chemically induced protein interactions.

Conclusions:

  • Proximity pharmacology offers vast potential for developing novel therapeutics.
  • Further innovation in design principles and biochemical mechanisms will expand the reach of proximity-based treatments.
  • Key areas ripe for innovation include novel protein-protein interaction triggers and degradation pathways.